We need to put these things in place. Let's see, we've had the Northeast, New York. We've had the Midwest. We've had western Pennsylvania. How about Texas? Let's go to Texas. Sheila Jackson Lee, thank you for joining us tonight.

Mr. Speaker, I want to join with my colleagues this evening to take up an extremely important subject. This is about the heart and soul and the opportunity of the middle class of America. This is about, once again, rebuilding the great…

Thank you very much, Mr. Blumenauer, and your work on this has been noted for a long, long time. You've been a leader across this Nation on providing all types of transportation well beyond just the bicycle, which you happen to have on…

U.S. innovation policy includes patent law, antitrust, tax and immigration. I don't see it separately.

Exportation of jobs offshore for cheap labor is increasingly a highlighted issue in this country.

It was terrible for business, it was terrible from a public safety standpoint. The Coast Guard couldn't even get in and out of the harbor.

I think it is about jobs.

I represent a number of ports in my district on the West Coast. And I have seen firsthand how deferred maintenance and a lack of funding and attention has really hurt our area.

Mr. President, the Honest Leadership and Open Government Act of 2007, the ``Act'', calls for the Select Committee on Ethics of the U.S. Senate to issue an annual report not later than January 31 of each year providing information in…

I agree, it is critical to retain that sunset provision so we have an opportunity to evaluate these questions, both the balance and the research questions as well.

Thank you, Mr. Chairman.

Above all else, we must ensure that the prescriptions our children use are tested appropriately and deemed safe.

I want to thank Representatives Mike Rogers and Anna Eshoo, who are leading the reauthorization efforts on these important laws.

When we examine claims as serious as these, we must insist on data and on facts.

I hope we would all agree that FDA should not take jobs into consideration when it is reviewing the safety and effectiveness of a new medicine.

It would be irresponsible to allow this legislation to become a vehicle for the wish lists of members seeking to move their own controversial bills.

We must reauthorize and establish these essential programs in a timely way so that FDA can do its job protecting the health and safety of American patients.

It will help make sure that--it will help identify contaminations and sources of contaminations, and it will help us put procedures in place to make sure that there are standards on the cement and casings to prevent contamination.